Progress in the treatment of pediatric H3 K27M mutant diffuse midline glioma
The high-grade glioma, H3 K27M mutant diffuse midline glioma tends to occur in children, and its high malignancy lead to very poor prognosis after treatment (median survival after diagnosis < 1 year). At present, there is no standard treatment for pediatric diffuse midline glioma; surgery, conven...
Main Authors: | Min⁃jie LUO, Jia⁃zhi CHEN, Wang⁃ming ZHANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Tianjin Huanhu Hospital
2020-04-01
|
Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
Subjects: | |
Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/2118 |
Similar Items
-
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
by: Hideaki Abe, et al.
Published: (2020-01-01) -
Diffuse midline glioma, H3-K27M mutant: Awareness leads to identification
by: Sadhana Tiwari, et al.
Published: (2019-01-01) -
Precision treatment exploration in a patient with diffuse midline glioma
by: Xiang⁃yu SHI, et al.
Published: (2019-12-01) -
A longitudinally extensive H3 K27M-mutant diffuse midline
glioma in an elderly patient clinically mimicking central nervous
system inflammation: a case report
by: Kristof Babarczy, et al.
Published: (2021-01-01) -
Multimodal MR imaging signatures to identify brain diffuse midline gliomas with H3 K27M mutation
by: Xiaorui Su, et al.
Published: (2022-02-01)